DXCM vs. EW: DexCom vs. Edwards Lifesciences Stock Comparison
How do DexCom (DXCM) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Edwards Lifesciences (EW) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | DXCM | EW |
|---|---|---|
| Name | DexCom Inc. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 29.62 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | April 14, 2005 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | EW |
|---|---|---|
| Total Return (1Y) | 46.33% | 25.08% |
| Total Return (3Y, Annualized) | -4.50% | 17.28% |
| Total Return (5Y, Annualized) | -12.76% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DXCM | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 25.58% |
| Beta (5Y) | 1.43 | 0.78 |
| Max Drawdown (5Y) | -66.32% | -54.32% |
| Avg. Volume (3M) | 4.34M | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | EW |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | 0.81 |
| Sortino Ratio (1Y) | 1.79 | 1.23 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for DXCM.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both DexCom (DXCM) at 19.42% and Edwards Lifesciences (EW) at 15.30% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both DexCom (DXCM) at 24.34% and Edwards Lifesciences (EW) at 30.15% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | EW |
|---|---|---|
| ROE (TTM) | 37.67% | 9.33% |
| ROA (TTM) | 11.14% | 8.77% |
| Net Margin (TTM) | 19.42% | 15.30% |
| Operating Margin (TTM) | 24.34% | 30.15% |
| Gross Margin (TTM) | 63.42% | 78.02% |
Growth
Revenue Growth
Both DexCom (DXCM) at 15.60% and Edwards Lifesciences (EW) at 11.55% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Edwards Lifesciences (EW) at -73.74% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | DXCM | EW |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 11.55% |
| Revenue Growth (3Y CAGR) | 17.01% | 10.77% |
| EPS Growth (YoY) | 47.18% | -73.74% |
| EPS Growth (3Y CAGR) | 36.60% | -9.14% |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while DexCom (DXCM) at 0.55 runs a more typical debt-to-equity mix.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | EW |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 4.60 |
| Debt / Equity (MRQ) | 0.55 | 0.06 |
| Net Debt / EBITDA | -0.28 | -1.88 |
Dividends
Dividend Yield (TTM)
Neither DexCom (DXCM) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DexCom (DXCM) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
DexCom (DXCM) at 31.26 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both DexCom (DXCM) at 5.80 and Edwards Lifesciences (EW) at 8.80 command a richer price per dollar of sales than most peers, sitting in the upper P/S ratio quartile of their industries.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Edwards Lifesciences (EW) at 5.41 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | EW |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 59.38 |
| P/S Ratio (TTM) | 5.80 | 8.80 |
| P/B Ratio (MRQ) | 11.68 | 5.41 |
| Free Cash Flow Yield (TTM) | 2.74% | 1.95% |